Dose range study in healthy volunteers of a hepatitis B vaccine produced in yeast.
D000328:Adult; D000956:Antigens, Viral / Q000276:immunology; D004274:DNA, Recombinant; D004306:Dose-Response Relationship, Immunologic; D004311:Double-Blind Method; D005260:Female; D006509:Hepatitis B / Q000276:immunology* / Q000382:microbiology; D006510:Hepatitis B Antibodies / Q000096:biosynthesis*; D006514:Hepatitis B Surface Antigens / Q000008:administration & dosage / Q000276:immunology* / Q000302:isolation & purification; D017325:Hepatitis B Vaccines; D006801:Humans; D007117:Immunization, Secondary; D008297:Male; D011897:Random Allocation; D012441:Saccharomyces cerevisiae / Q000235:genetics / Q000276:immunology; D014170:Transformation, Genetic; D014611:Vaccination; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage* / Q000276:immunology
D000956:Antigens, Viral; D004274:DNA, Recombinant; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines